Metethoheptazine
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
Synonyms | WY-535 |
CAS Number | 509-84-2 |
PubChem (CID) | 176888 |
ChemSpider | 154060 |
UNII | S36J5ZY2TH |
Chemical and physical data | |
Formula | C17H25NO2 |
Molar mass | 275.39 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]
Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
- ↑ GB Patent 843924
- ↑ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH. Metabolism of the Non-Narcotic Analgesic, WY-535. Biochemical Pharmacology. 1965 Feb;14:121-8.
- ↑ http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html
This article is issued from Wikipedia - version of the 5/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.